Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Heranba Industries Ltd

HERANBA
NSE
223.06
1.29%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Heranba Industries Ltd

HERANBA
NSE
223.06
1.29%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
893Cr
Close
Close Price
223.06
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
PS
Price To Sales
0.55
Revenue
Revenue
1,610Cr
Rev Gr TTM
Revenue Growth TTM
20.81%
PAT Gr TTM
PAT Growth TTM
-241.11%
Peer Comparison
How does HERANBA stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
HERANBA
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
260275424300258296437341335452522301
Growth YoY
Revenue Growth YoY%
-24.00.98.6-0.97.73.113.929.852.719.3-11.7
Expenses
ExpensesCr
240279380275246256378329349421473289
Operating Profit
Operating ProfitCr
20-4442412406013-14314912
OPM
OPM%
7.9-1.510.48.14.813.613.63.7-4.36.99.44.1
Other Income
Other IncomeCr
36225130313-34
Interest Expense
Interest ExpenseCr
3223556614121212
Depreciation
DepreciationCr
6666813141416212626
PBT
PBTCr
15-6381742443-7-41118-22
Tax
TaxCr
3-1113475315102
PAT
PATCr
11-62714-11738-10-426-2-23
Growth YoY
PAT Growth YoY%
-116.8-42.910.1-106.5396.340.0-174.5-5,608.2-62.0-105.7-126.0
NPM
NPM%
4.3-2.06.34.7-0.35.68.6-3.0-12.41.4-0.4-7.8
EPS
EPS
2.8-1.46.73.5-0.14.29.5-2.5-10.41.50.4-5.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
1,3191,2571,4101,610
Growth
Revenue Growth%
-4.712.114.2
Expenses
ExpensesCr
1,1631,1801,3121,532
Operating Profit
Operating ProfitCr
156779878
OPM
OPM%
11.86.17.04.8
Other Income
Other IncomeCr
1214817
Interest Expense
Interest ExpenseCr
8123150
Depreciation
DepreciationCr
23265788
PBT
PBTCr
1385218-44
Tax
TaxCr
33181617
PAT
PATCr
104352-61
Growth
PAT Growth%
-66.9-93.5-2,808.0
NPM
NPM%
7.92.70.2-3.8
EPS
EPS
26.18.70.8-14.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
40404040
Reserves
ReservesCr
770803801802
Current Liabilities
Current LiabilitiesCr
3395918601,230
Non Current Liabilities
Non Current LiabilitiesCr
1336103104
Total Liabilities
Total LiabilitiesCr
1,1621,4801,8132,184
Current Assets
Current AssetsCr
8448401,0331,386
Non Current Assets
Non Current AssetsCr
318639780798
Total Assets
Total AssetsCr
1,1621,4801,8132,184

Cash Flow

Consolidated
Standalone
Financial YearMar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
107101
Investing Cash Flow
Investing Cash FlowCr
-241-239
Financing Cash Flow
Financing Cash FlowCr
62152
Net Cash Flow
Net Cash FlowCr
-7214
Free Cash Flow
Free Cash FlowCr
-145-137
CFO To PAT
CFO To PAT%
310.74,502.2
CFO To EBITDA
CFO To EBITDA%
139.5103.5

Ratios

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,1181,134852
Price To Earnings
Price To Earnings
10.732.5276.4
Price To Sales
Price To Sales
0.80.90.6
Price To Book
Price To Book
1.41.41.0
EV To EBITDA
EV To EBITDA
7.016.411.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.131.133.0
OPM
OPM%
11.86.17.0
NPM
NPM%
7.92.70.2
ROCE
ROCE%
16.16.44.1
ROE
ROE%
12.94.10.3
ROA
ROA%
9.02.30.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Heranba Industries Limited (HIL) is a leading Indian agrochemical company with fully integrated operations across the synthetic pyrethroid and broader agrochemical value chain. Founded in 1992 (note: alternate references cite 1994) by technocrats Sadashiv K. Shetty and Raghuram K. Shetty in Vapi, Gujarat, the company has evolved from an intermediate manufacturer into a vertically integrated player producing **intermediates, technical-grade agrochemicals, branded formulations, and public health products**. HIL operates seven manufacturing and packaging facilities across Gujarat (Vapi, Saykha, Sarigam) and Maharashtra (Boisar), serving over 225 international customers and maintaining a strong domestic presence via a network of 10,000+ dealers across 20 Indian states and UTs. --- ### **Core Business Segments & Product Portfolio** Heranba operates across three primary business verticals: 1. **Domestic Sales of Technicals** 2. **Export Sales of Technicals** 3. **Branded Formulations (Domestic)** #### **Key Products:** - **Insecticides:** Synthetic pyrethroids (e.g., Cypermethrin, Deltamethrin, Alpha Cypermethrin, Lambda Cyhalothrin, Permethrin), Neonicotinoids, Organophosphorus - **Herbicides:** Glyphosate, Metribuzin, Bispyribac Sodium, and new off-patent molecules - **Fungicides:** Tricyclazole, Hexaconazole, and developing products for rice, fruits, and vegetables - **Public Health Products:** Larvicides and insecticides marketed under brands like *Alpha Shakti-5WP*, *Temper EC*, and *Deltaflow* The company is recognized as **one of India’s largest producers of synthetic pyrethroids**, known for their eco-friendly profile compared to older chemical classes. --- ### **Operational Strength & Manufacturing Capabilities** - **Manufacturing Footprint:** 7 integrated facilities (as of Nov 2025) across Vapi, Saykha, and Sarigam (Gujarat), with a combined area of 124,970 sq. m. and ~72,000 sq. m. available for expansion. - **Production Capacity (FY25):** - **Intermediates & Technicals:** 26,700 MTPA (more than doubled since FY21) - **Formulations:** 30,000 MTPA - **Reactor Base:** Over 384 reactors across facilities, enabling advanced processes like hydrogenation, halogenation, esterification, and diastereoselective synthesis. - **Backward Integration:** In-house production of key intermediates such as CMAC, MPBAL, and Bromobenzene, enabling cost control and supply chain security. - **Recent Expansions (FY25):** - Phase I of Saykha Unit commissioned in April 2025 - Phase II of Sarigam Unit commissioned in July 2025 - These projects significantly boosted AI capacity and supported diversification into herbicides and fungicides. --- ### **Revenue Mix & Market Diversification (FY25)** - **48%** of revenue from **domestic branded formulations** - **8%** from **formulation exports** - **29%** from **technicals exports** - The formulations business (domestic + export) now contributes **>56% of total revenue**, indicating a strategic shift toward higher-margin products. - **41–42% of revenue** comes from exports (as of FY22–FY24), with a long-term target of **60% export mix**. - Top 10 customers account for ~15% of revenue (FY24), indicating a diversified customer base. --- ### **R&D, Innovation & Regulatory Edge** - **R&D Investment:** ₹6.45 crore in FY25 - **R&D Infrastructure:** 3 in-house centers recognized by DSIR; labs certified under ISO 9001, ISO 14001, and NABL (ISO/IEC 17025) - **Key Instruments:** HPLC, GC, UV-Vis, electron microscopes, bead mills, air jet mills, fluidized bed dryers - **Recent R&D Output (FY25):** - 5 new herbicides (3 launched) - 4 fungicides (3 launched) - 3 insecticides (2 piloted and launched in select markets) - **Product Registrations:** - **1,084 cumulative registrations** across **54+ countries** (up from 892 in FY23) - **183 products in pipeline**, with focus on regulated markets - **Strategic Priority:** Securing registrations in **regulated markets (USA, Europe, Brazil)**, with early approvals received in the U.S. and additional filings underway. --- ### **Global Expansion & Market Access** - **Geographic Presence:** Operates in **>75 countries**, including developed markets (U.S., Europe), emerging Asia (Bangladesh, Indonesia, Vietnam, China), CIS, Middle East, Africa, and Latin America. - **Strategic Entry into Developed Markets:** - Successfully launched first insecticide in U.S. in Oct 2021. - Plans to generate **$25 million in U.S. sales** in the coming years. - Targeting $50 million long-term opportunity in U.S. market. - Developing molecules tailored for the U.S., Europe, and Brazil. - **Distribution Model:** - **Exports:** Sold via international partners who register and brand products locally (B2B technicals and formulations). - **Domestic:** Direct-to-farmer via 10,000+ dealers and 31 stock depots. --- ### **Key Strategic Initiatives (FY25–FY27)** 1. **Entry into CRAMS/CRO/CDMO Space:** - Achieved through the **acquisition of Daikaffil Chemicals India Limited** (Tarapur, Maharashtra), providing land, infrastructure, and capabilities. - A new **R&D and pilot plant center** with **15 reactors** is under development; Phase I scheduled for **completion by Q1 FY27**. - Investment: ₹50 crore allocated for Phase I. - Will offer end-to-end services in **agrochemicals, pharmaceuticals, biopharmaceuticals, plant nutrition, and specialty chemicals**. - Plans to hire **60 new scientists** in synthetic chemistry, analytical R&D, and formulation development. 2. **Capacity Expansion & CAPEX:** - Over ₹1,200 crore invested in CAPEX since FY22. - Expansion at Sarigam and Saykha facilities has more than doubled AI capacity. - Future CAPEX planned for fermentation technology, performance chemicals, and GLP-certified facilities (Phase II). 3. **Diversification Beyond Pyrethroids:** - Historically ~70–75% insecticide-focused, but now shifting toward **50:50 split between pyrethroids and non-pyrethroids**, expected to become **40:60** in favor of other agrochemicals within 2 years. - New capacity supports fungicides and herbicides commercialization. 4. **Focus on Regulated Markets:** - Actively commercializing off-patent agrochemicals in the U.S. and Europe. - Regulatory dossiers prepared internally or through partners. - Multiple pyrethroid (lambda cyhalothrin, deltamethrin) and herbicide registrations obtained or in pipeline in U.S. and EU. --- ### **Management & Leadership Updates (Nov 2025)** - Appointed a **new Vice President of Sales & Marketing** based in Mumbai with **25+ years of experience** in the agri-industry. - New incumbent holds **MBA in Marketing** and **B.Sc. in Agriculture (Hons.)**. - Core expertise: **Go-to-market strategies, new product launches, commercial leadership** in crop protection and nutrition. - This appointment signals a renewed focus on scaling domestic branded formulations and enhancing commercial execution.